本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

4.21
-0.1700-3.88%
盘后4.250.0400+0.95%19:42 EDT
成交量:129.20万
成交额:551.73万
市值:2.88亿
市盈率:-2.16
高:4.57
开:4.46
低:4.14
收:4.38
数据加载中...
2023/11/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/23

重要事件披露

Form 8-K - Current report
2023/10/19

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/10/17

重要事件披露

Form 8-K - Current report
2023/10/10

重要事件披露

Form 8-K - Current report
2023/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/09/05

重要事件披露

Form 8-K - Current report
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities